lg 100268 has been researched along with tamoxifen in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brose, HL; Gould, MN; Haag, JD; Hitt, AA; Hu, R; Kim, K; Lindstrom, MJ; Lubet, RA; Mau, B; Monson, DM; Steele, VE; Waller, JL; Watson, PA; Woditschka, S; Zheng, Y | 1 |
Bissonnette, RP; Brown, PH; Edwards, DE; Hill, JL; Kittrell, FS; Mazumdar, A; Medina, D; Zhang, Y | 1 |
2 other study(ies) available for lg 100268 and tamoxifen
Article | Year |
---|---|
Neu-induced retroviral rat mammary carcinogenesis: a novel chemoprevention model for both hormonally responsive and nonresponsive mammary carcinomas.
Topics: Animals; Anticarcinogenic Agents; Bexarotene; Body Weight; Disease Models, Animal; Female; Genes, erbB-2; Genetic Vectors; Mammary Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Nicotinic Acids; Rats; Rats, Inbred WF; Retroviridae; Tamoxifen; Tetrahydronaphthalenes | 2006 |
The combination of tamoxifen and the rexinoid LG100268 prevents ER-positive and ER-negative mammary tumors in p53-null mammary gland mice.
Topics: Animals; Blotting, Western; Bone Density Conservation Agents; Female; Immunoenzyme Techniques; Mammary Neoplasms, Experimental; Mammary Tumor Virus, Mouse; Mice; Mice, Inbred BALB C; Nicotinic Acids; Real-Time Polymerase Chain Reaction; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tamoxifen; Tetrahydronaphthalenes; Tumor Suppressor Protein p53 | 2012 |